99-0123: LAMIVUDINE AND ZIDOVUDINE TABLET.
LAMIVUDINE AND ZIDOVUDINE TABLET. Key specifications include administration: ORAL, special_features: LAMIVUDINE AND ZIDOVUDINE TABLETS; 150MG LAMIVUDINE AND 300MG ZIDOVUDINE, primary_container_type: BOTTLE, primary_container_content_quantity: 60.000 TABLETS, part_name_assigned_by_controlling_agency: LAMIVUDINE AND ZIDOVUDINE TABLETS 60S BT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-462-9945, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| special_features | LAMIVUDINE AND ZIDOVUDINE TABLETS; 150MG LAMIVUDINE AND 300MG ZIDOVUDINE |
| primary_container_type | BOTTLE |
| primary_container_content_quantity | 60.000 TABLETS |
| part_name_assigned_by_controlling_agency | LAMIVUDINE AND ZIDOVUDINE TABLETS 60S BT |
| NSN | 6505-01-462-9945 |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 60.000 TABLETS |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | LAMIVUDINE AND ZIDOVUDINE TABLETS; 150MG LAMIVUDINE AND 300MG ZIDOVUDINE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LAMIVUDINE AND ZIDOVUDINE TABLETS 60S BT |